Metformin study for prediabetes halted before it began
NCT ID NCT06526494
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study aimed to see if metformin improves blood vessel function in adults aged 18-55 with prediabetes. Participants would have taken metformin or a placebo for 12 weeks. However, the study was withdrawn before enrolling anyone, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52245, United States
Conditions
Explore the condition pages connected to this study.